GlassScriptPhysician profile
Melanie Georgalas
NPI 1740200088
$696.60
in general payments reported to CMS, 2019-2025
12 companies · $24.17 in 2025
The $24.17 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.09 · 2020: $51.75 · 2021: $67.61 · 2022: $235 · 2023: $155 · 2024: $89.26 · 2025: $24.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $268.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $202.51 | 2022-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $80.61 | 2023-2024 | Jornay Pm |
| Tris Pharma INC | $74.03 | 2019-2022 | |
| Kaleo, INC. | $69.26 | 2019-2024 | Auvi-Q |
| Merck Sharp & Dohme LLC | $67.31 | 2021-2022 | |
| Glaxosmithkline, LLC. | $46.41 | 2022-2024 | Bexsero, Rotarix |
| Takeda Pharmaceuticals U.S.A., INC. | $46.16 | 2021-2022 | |
| Sanofi Pasteur INC. | $42.44 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $24.17 | 2025 | Jornay Pm |
| Shire North American Group INC | $15.17 | 2019 | |
| Supernus Pharmaceuticals, INC. | $14.72 | 2023 | Qelbree |
| Genentech USA, INC. | $13.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Georgalas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.